Public Profile

Allergan Finance, LLC

Allergan Finance, LLC, a prominent player in the pharmaceutical and biotechnology industry, is headquartered in the United States. Founded in 1983, the company has established itself as a leader in the development of innovative medical aesthetics, eye care, and neuroscience products. With a strong presence in North America and Europe, Allergan Finance is renowned for its flagship offerings, including the popular Botox® treatment and a range of dermal fillers. The company has achieved significant milestones, including its acquisition by AbbVie in 2020, which further solidified its market position. Allergan Finance is committed to advancing healthcare solutions that enhance patient outcomes, making it a trusted name in the industry. Its unique focus on both aesthetic and therapeutic applications sets it apart, ensuring a diverse portfolio that meets the evolving needs of healthcare professionals and patients alike.

DitchCarbon Score

How does Allergan Finance, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

35

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Allergan Finance, LLC's score of 35 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Allergan Finance, LLC's reported carbon emissions

Allergan Finance, LLC, headquartered in the US, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of information suggests that Allergan Finance may still be in the early stages of formalising its climate commitments or reporting on its emissions. In the context of the pharmaceutical industry, companies are increasingly expected to adopt robust sustainability practices and set measurable targets to reduce their carbon footprint. As such, Allergan Finance's future climate strategies will be crucial in aligning with industry standards and addressing global climate challenges.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Allergan Finance, LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Allergan Finance, LLC is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Allergan Finance, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Glaxosmithkline

GB
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Tesaro, Inc.

US
Health and social work services (85)
Updated 3 months ago
DitchCarbon Score

Heron Therapeutics, Inc.

US
Health and social work services (85)
Updated 3 days ago

Kyowa Kirin

JP
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Sanofi

FR
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

P AND L DEVELOPMENT LLC

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers